{"DataElement":{"publicId":"7409843","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy Aplastic Anemia Response Type","preferredDefinition":"A description of the best response to therapy for aplastic anemia.","longName":"2946463v1.0:7409461v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2946463","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Having the most positive qualities._The result of therapy for a given disease or condition in a patient or group of patients.","longName":"2404658v1.0:3194600v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3194600","version":"1","preferredName":"Best Outcome of Therapy","preferredDefinition":"Having the most positive qualities.:The result of therapy for a given disease or condition in a patient or group of patients.","longName":"C25432:C18919","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome of Therapy","conceptCode":"C18919","definition":"The result of therapy for a given disease or condition in a patient or group of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D80CD45-BE7A-5B19-E040-BB89AD430E80","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-02","modifiedBy":"ONEDATA","dateModified":"2011-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"747EBAC6-25E8-A734-E040-BB89AD43588E","latestVersionIndicator":"Yes","beginDate":"2009-09-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7409461","version":"1","preferredName":"Aplastic Anemia Response Type","preferredDefinition":"A condition in which the bone marrow is unable to produce blood cells._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._Something distinguishable as an identifiable class based on common qualities.","longName":"7409461v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Complete","valueDescription":"Complete Response in Aplastic Anemia","ValueMeaning":{"publicId":"7409840","version":"1","preferredName":"Complete Response in Aplastic Anemia","longName":"7409840","preferredDefinition":"A hematologic response to treatment for aplastic anemia that meets the criteria of normal hemoglobin level for age, absolute neutrophil count, and platelet count.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Response in Aplastic Anemia","conceptCode":"C174195","definition":"A hematologic response to treatment for aplastic anemia that meets the criteria of normal hemoglobin level for age, absolute neutrophil count, and platelet count.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF476EF-09C8-63C3-E053-4EBD850A957C","latestVersionIndicator":"Yes","beginDate":"2020-08-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-08-28","modifiedBy":"ONEDATA","dateModified":"2020-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADF476EF-09E0-63C3-E053-4EBD850A957C","beginDate":"2020-08-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-08-28","modifiedBy":"ONEDATA","dateModified":"2020-08-28","deletedIndicator":"No"},{"value":"None / recurrence of transfusion dependence","valueDescription":"No Response in Aplastic Anemia","ValueMeaning":{"publicId":"7409841","version":"1","preferredName":"No Response in Aplastic Anemia","longName":"7409841","preferredDefinition":"Worsening of, or no apparent change in, the severity of aplastic anemia in response to treatment, including recurrence of transfusion dependency.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Response in Aplastic Anemia","conceptCode":"C174197","definition":"Worsening of, or no apparent change in, the severity of aplastic anemia in response to treatment, including recurrence of transfusion dependency.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF476EF-09EC-63C3-E053-4EBD850A957C","latestVersionIndicator":"Yes","beginDate":"2020-08-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-08-28","modifiedBy":"ONEDATA","dateModified":"2020-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADF476EF-0A05-63C3-E053-4EBD850A957C","beginDate":"2020-08-27","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-08-28","modifiedBy":"ONEDATA","dateModified":"2020-08-28","deletedIndicator":"No"},{"value":"Partial","valueDescription":"Partial Response in Aplastic Anemia","ValueMeaning":{"publicId":"7411303","version":"1","preferredName":"Partial Response in Aplastic Anemia","longName":"7411303","preferredDefinition":"A hematologic response to treatment for aplastic anemia that does not meet the criteria for a complete response, but meets the criteria for less severe disease and allows the patient to become or remain transfusion-independent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Response in Aplastic Anemia","conceptCode":"C174196","definition":"A hematologic response to treatment for aplastic anemia that does not meet the criteria for a complete response, but meets the criteria for less severe disease and allows the patient to become or remain transfusion-independent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE47693B-2C9E-5C8C-E053-4EBD850A70C8","latestVersionIndicator":"Yes","beginDate":"2020-09-01","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-09-01","modifiedBy":"ONEDATA","dateModified":"2020-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE47693B-2CB7-5C8C-E053-4EBD850A70C8","beginDate":"2020-08-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-09-01","modifiedBy":"ONEDATA","dateModified":"2020-09-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7409909","version":"1","preferredName":"Aplastic Anemia Disease Response Type","preferredDefinition":"A condition in which the bone marrow is unable to produce blood cells.:The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.:Something distinguishable as an identifiable class based on common qualities.","longName":"C2870:C50995:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aplastic Anemia","conceptCode":"C2870","definition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well. Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF37C42-9C78-60F7-E053-4EBD850AC654","latestVersionIndicator":"Yes","beginDate":"2020-08-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-08-28","modifiedBy":"ONEDATA","dateModified":"2020-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADE1C1FE-6A4A-35C7-E053-4EBD850AB597","latestVersionIndicator":"Yes","beginDate":"2020-08-27","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-08-27","modifiedBy":"MALUMK","dateModified":"2020-12-03","changeDescription":"Released. 12/03/2020 KMM; Released. 12/03/2020 KMM; Released. 12/03/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Data Element Disease or Disorder Best Outcome of Therapy Aplastic Anemia Response Type does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Disease or Disorder Best Outcome of Therapy Aplastic Anemia Response Type does not have Preferred Question Text","url":null,"context":"NHLBI"},{"name":"Best response to line of therapy","type":"Application Standard Question Text","description":"Best response to line of therapy","url":null,"context":"NHLBI"},{"name":"Best response to line of therapy","type":"Alternate Question Text","description":"Best response to line of therapy","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF476EF-0A0F-63C3-E053-4EBD850A957C","latestVersionIndicator":"Yes","beginDate":"2020-08-28","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-08-28","modifiedBy":"MALUMK","dateModified":"2020-12-03","changeDescription":"Released. 12/03/2020 KMM; System generated def displayed as alt def. 08/28/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}